Proteomics International Laboratories Ltd. (PIQ) Price & Analysis

Compare

32 Followers

PIQ Stock Chart & Stats

AU$0.67

AU$0.03(4.23%)

At close: Jan 09 4:00 PM EST

AU$0.67

AU$0.03(4.23%)

Day’s Range― - ―

52-Week RangeAU$0.29 - AU$0.86

Previous CloseN/A

Volume90.30K

Average Volume (3M)426.90K

Market Cap

AU$54.51M

Enterprise ValueAU$46.70M

Total Cash (Recent Filing)AU$7.67M

Total Debt (Recent Filing)AU$681.45K

Price to Earnings (P/E)―

Beta1.17

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding165,184,000

10 Day Avg. Volume295,611

30 Day Avg. Volume426,904

Financial Highlights & Ratios

PEG Ratio-0.84

Price to Book (P/B)3.69

Price to Sales (P/S)50.61

P/FCF Ratio-7.33

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$0.43

Price Target Upside-35.82% Downside

Rating ConsensusModerate Sell

Number of Analyst Covering1

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low LeverageA very low debt-to-equity ratio (0.021) gives the company durable financial flexibility, lowering default and refinancing risk. This supports continued R&D and commercialization spending without large interest burdens, preserving strategic optionality over the next 2-6 months.

Diversified Revenue ModelRevenue split between diagnostic product/testing and fee-for-service proteomics gives structural resilience. Contract lab work generates repeatable fee income while diagnostics offer scale and licensing upside, reducing reliance on a single revenue source long-term.

Positive Gross MarginA positive gross margin indicates the core testing and services can be economically viable if fixed operating costs are controlled. This provides a pathway to profitability once sales scale or operating expenses are managed, supporting medium-term margin recovery.

Bears Say

Steep Revenue DeclineA ~72% revenue collapse signals loss of customers, lower test volumes or commercialization setbacks. Such structural top-line deterioration undermines scale economics, lengthens the runway to break-even and makes investment in commercialization riskier over months ahead.

Sustained Operating LossesPersistent negative EBIT and net margins show operations do not yet cover overhead and R&D. Continued losses erode equity and constrain reinvestment, making the business dependent on external funding or rapid revenue recovery to sustain operations over the medium term.

Negative Operating Cash FlowNegative operating and free cash flow indicate cash burn from core activities. Even with some alignment between FCF and net income, ongoing outflows limit liquidity, increase financing risk, and pressure management to cut costs or raise capital within the next several months.

Proteomics International Laboratories Ltd. News

Proteomics International Widens Half-Year Loss as Revenue Declines

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) has provided an announcement. Proteomics International Laboratories reported a weak first...

10d ago

PIQ

Proteomics International Founder Dr Richard Lipscombe Retires from Board

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) has shared an update. Proteomics International Laboratories Ltd announced the formal...

12d ago

PIQ

Proteomics International Seeks ASX Quotation for Additional 67,566 Shares

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) just unveiled an announcement. Proteomics International Laboratories Ltd has applied to...

1M ago

PIQ

Proteomics International Seeks ASX Quotation for 1.16m New Shares

The latest announcement is out from Proteomics International Laboratories Ltd. ( ($AU:PIQ) ). Proteomics International Laboratories Ltd has...

2M ago

PIQ

Proteomics International Appoints David Morris to Board With No Initial Shareholding

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) has issued an announcement. Proteomics International Laboratories Ltd has appointed David...

2M ago

PIQ

Proteomics International Wins Canadian Patent for PromarkerEso Esophageal Cancer Test

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) just unveiled an update. Proteomics International Laboratories has secured a Canadian...

2M ago

PIQ

Proteomics International Seeks ASX Quotation for 147,286 New Shares

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) has issued an update. Proteomics International Laboratories Ltd has applied to...

2M ago

PIQ

Proteomics International Names David Morris CEO to Lead Global Commercial Push

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) has provided an update. Proteomics International Laboratories has appointed David Morris...

2M ago

PIQ

Proteomics International Seeks ASX Quotation for Additional 32,430 Shares

An announcement from Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) is now available. Proteomics International Laboratories Ltd has...

2M ago

PIQ

Proteomics International Announces Lapse of 15,072 Employee Performance Rights

Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) just unveiled an announcement. Proteomics International Laboratories Ltd has notified the...

2M ago

PIQ

PIQ FAQ

What was Proteomics International Laboratories Ltd.’s price range in the past 12 months?

Proteomics International Laboratories Ltd. lowest share price was AU$0.28 and its highest was AU$0.86 in the past 12 months.

What is Proteomics International Laboratories Ltd.’s market cap?

Proteomics International Laboratories Ltd.’s market cap is AU$54.51M.

When is Proteomics International Laboratories Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Proteomics International Laboratories Ltd.’s earnings last quarter?

Currently, no data Available

Is Proteomics International Laboratories Ltd. overvalued?

According to Wall Street analysts Proteomics International Laboratories Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Proteomics International Laboratories Ltd. pay dividends?

Proteomics International Laboratories Ltd. does not currently pay dividends.

What is Proteomics International Laboratories Ltd.’s EPS estimate?

Proteomics International Laboratories Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Proteomics International Laboratories Ltd. have?

Proteomics International Laboratories Ltd. has 165,184,000 shares outstanding.

What happened to Proteomics International Laboratories Ltd.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Proteomics International Laboratories Ltd.?

Currently, no hedge funds are holding shares in AU:PIQ

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Proteomics International Laboratories Ltd. Stock Smart Score

Neutral

Fundamentals

Return on Equity

-71.87%

Trailing 12-Months

Asset Growth

35.92%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Proteomics International Laboratories Ltd.

Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute and the Janssen Research & Development for the research of diabetic kidney disease treatment; and partnership with QIMR Berghofer Medical Research Institute for the detection of oesophageal adenocarcinoma. The company was founded in 2001 and is based in Perth, Australia.

Proteomics International Laboratories Ltd. (PIQ) Earnings & Revenues

Historic Earnings Reports

PIQ Stock 12 Month Forecast

Average Price Target

AU$0.43

▼(-35.82% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","-1":"-AU$1","-0.5":"-AU$0.5","0.5":"AU$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$0.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$0.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.43,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$0.43</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.315,0.32384615384615384,0.3326923076923077,0.34153846153846157,0.3503846153846154,0.35923076923076924,0.3680769230769231,0.3769230769230769,0.38576923076923075,0.3946153846153846,0.4034615384615384,0.4123076923076923,0.42115384615384616,{"y":0.43,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.315,0.32384615384615384,0.3326923076923077,0.34153846153846157,0.3503846153846154,0.35923076923076924,0.3680769230769231,0.3769230769230769,0.38576923076923075,0.3946153846153846,0.4034615384615384,0.4123076923076923,0.42115384615384616,{"y":0.43,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.315,0.32384615384615384,0.3326923076923077,0.34153846153846157,0.3503846153846154,0.35923076923076924,0.3680769230769231,0.3769230769230769,0.38576923076923075,0.3946153846153846,0.4034615384615384,0.4123076923076923,0.42115384615384616,{"y":0.43,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.86,"date":1669852800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.79,"date":1725148800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.8,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.48,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.42,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.36,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.32,"date":1756684800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.34,"date":1761955200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 33, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.4,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 40, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.72,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 52, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 8</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.505,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 70, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":0.315,"date":1772323200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 63, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >